SAN FRANCISCO — Elon Musk’s (picture) brain computer interface startup Neuralink announced on Monday that it has closed a US$650 million funding round, Xinhua reported.
The Series E fundraiser included investors such as ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others, the company said in a blog post.
Neuralink last raised a US$280 million Series D funding round in 2023, with an additional US$43 million tranche added months later.
The company said it has now conducted more human clinical trials, implanting its brain chips in five individuals with severe paralysis.
In May, Neuralink received a Breakthrough Devices Programme designation from the US Food and Drug Administration (FDA).
The Breakthrough Devices Programme is a voluntary programme for certain medical devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions, according to the FDA.
The programme is intended to provide patients and healthcare providers with timely access to medical devices by speeding up development, assessment, and review for premarket approval. — BERNAMA-XINHUA
RELATED ARTICLES
Musk’s millions for Trump make him biggest US political donor
Musk, SEC settle legal fight over his tweets about Tesla
Musk Seeks Twitter Investors at Same Price He Paid, Semafor Says
TVET or not TVET, that is the question
‘Work less’ is billionaire Maezawa’s secret behind SpaceX moon trip
Tesla engineers visit Twitter office to review code for Musk
The post Elon Musk’s Neuralink closes Series E funding round appeared first on The Malaysian Reserve.
